GI DYNAMICS, INC - Announcements

0.00%

0.2¢

Currently unlisted.

GI Dynamics, Inc. is a medical device company. The Company designs and applies device and... GI Dynamics, Inc. is a medical device company. The Company designs and applies device and disease management solutions for the treatment of metabolic disease. The Company designs, develops, manufactures and markets medical devices for non-surgical approaches to treat type II diabetes and obesity. The Company's product, EndoBarrier, is an endoscopically-delivered device therapy, which is approved for the treatment of obese type II diabetes with body mass index (BMI) greater than or equal to 30 kilogram/square meter (kg/m2), or obese patients with BMI greater than or equal to 30 kg/m2 with greater than or equal to one comorbidities, or obese patients with BMI over 35 kg/m2. EndoBarrier is an incision-free, non-anatomy altering solution designed to specifically mimic the duodenal-jejunal exclusion created by gastric bypass surgery.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

GID	ENDO Trial Placed on Enrollment Hold	PRICE SENSITIVE	06/03/15	142.69KB	Share
GID	Trading Halt request		05/03/15	458.73KB	Share
GID	Trading Halt	PRICE SENSITIVE	05/03/15	39.91KB	Share
GID	Preliminary Final Report	PRICE SENSITIVE	27/02/15	263.72KB	Share
GID	Appendix 3B		11/02/15	173.15KB	Share
GID	Executive Separation Agreement		03/02/15	82.33KB	Share
GID	Appendix 4C - quarterly	PRICE SENSITIVE	30/01/15	140.36KB	Share
GID	Appendix 3B		19/01/15	186.26KB	Share
GID	Corporate Restructuring and Departure of CFO	PRICE SENSITIVE	09/12/14	44.84KB	Share
GID	GI Dynamics Resumes Shipments of EndoBarrier Product	PRICE SENSITIVE	01/12/14	103.57KB	Share
GID	GI Dynamics to Present at the Piper Jaffray Healthcare Conf		19/11/14	37.31KB	Share
GID	Appendix 3B		14/11/14	191.09KB	Share
GID	Registration Statement on Form S-8 Filed with SEC		13/11/14	281.14KB	Share
GID	Results of Special Meeting of Stockholders		12/11/14	79.62KB	Share
GID	Form 10-Q Filed for 3rd Quarter 2014 with SEC	PRICE SENSITIVE	11/11/14	301.16KB	Share
GID	Final Director's Interest Notice		05/11/14	65.54KB	Share
GID	Director Appointment/Resignation		05/11/14	30.7KB	Share
GID	Change of Director's Interest Notice		31/10/14	113.73KB	Share
GID	Appendix 4C - quarterly	PRICE SENSITIVE	31/10/14	139.21KB	Share
GID	Notice of Extraordinary General Meeting/Proxy Form		30/10/14	42.7KB	Share
GID	Application for Listing on NASDAQ Capital Market		28/10/14	30.61KB	Share
GID	Briefing Call and Webcast on Financial Results for Q3 2014		28/10/14	39.33KB	Share
GID	Notice of Extraordinary General Meeting/Proxy Form		23/10/14	442.88KB	Share
GID +HHL	Change in substantial holding from HHL		14/10/14	110.17KB	Share
GID	GI Dynamics Suspends Shipments of CE Marked Product	PRICE SENSITIVE	06/10/14	88.89KB	Share
GID	Trading Halt	PRICE SENSITIVE	06/10/14	485.76KB	Share
GID	Initial Director's Interest Notice		19/09/14	67.91KB	Share
GID	Appendix 3B		19/09/14	173.69KB	Share
GID	New Clinical Data on EndoBarrier Therapy Presented at EASD	PRICE SENSITIVE	18/09/14	90.77KB	Share
GID	Appendix 3B		17/09/14	172.46KB	Share
GID	Change of Director's Interest Notice		15/09/14	75.22KB	Share
GID	Initial Director's Interest Notice		12/09/14	67.92KB	Share
GID	GI Dynamics Appoints Daniel Moore to the Board of Directors		11/09/14	32.83KB	Share
GID	Clinical Data on EndoBarrier Therapy to be Presented at EASD		09/09/14	72.17KB	Share
GID	New Clinical Data on EndoBarrier Therapy Presented at IFSO		29/08/14	36.14KB	Share
GID	Appointment of Michael Dale as President & CEO	PRICE SENSITIVE	29/08/14	125.65KB	Share
GID	Half Yearly Report and Accounts	PRICE SENSITIVE	15/08/14	366.09KB	Share
GID	Appendix 3B		14/08/14	169.44KB	Share
GID +HHL	Change in substantial holding from HHL		07/08/14	115.72KB	Share
GID	Appendix 4C - quarterly	PRICE SENSITIVE	31/07/14	138.92KB	Share
GID	Launch of EndoBarrier Therapy Clinical Study in France	PRICE SENSITIVE	30/07/14	72.31KB	Share
GID	Effectiveness of U.S. SEC Form 10 Registration Statement		21/07/14	31.45KB	Share
GID	Briefing Call and Webcast on Financial Results for Q2 2014		21/07/14	39.26KB	Share
GID	Appendix 3B		10/07/14	182.11KB	Share
GID	Departure of CCO & Update on 2nd Quarter Revenues	PRICE SENSITIVE	02/07/14	32.42KB	Share
GID +HHL	Becoming a substantial holder from HHL - corrected		20/06/14	109.29KB	Share
GID +HHL	Becoming a substantial holder from HHL		19/06/14	125.07KB	Share
GID	New EndoBarrier data presented at ADA meeting	PRICE SENSITIVE	16/06/14	89.21KB	Share
GID	New EndoBarrier data to be presented at ADA meeting		10/06/14	32.53KB	Share
GID	Change of Director's Interest Notice		04/06/14	77.08KB	Share
GID	Appendix 3B		04/06/14	196.78KB	Share
GID	Results of Meeting		22/05/14	91.01KB	Share
GID	Annual General Meeting - Withdrawal of Resolution 3		20/05/14	75.08KB	Share
GID	Reduced Reliance on Insulin by Patients with EndoBarrier	PRICE SENSITIVE	16/05/14	35.7KB	Share
GID	2014 Annual Meeting of Stockholders Webcast and Call		15/05/14	34.49KB	Share
GID	Becoming a substantial holder - CORRECTION		13/05/14	54.33KB	Share
GID	Becoming a substantial holder		13/05/14	54.28KB	Share
GID	Ceasing to be a substantial holder - CORRECTION		12/05/14	50.05KB	Share
GID	Two New Centres Offer EndoBarrier in Australia		12/05/14	44.03KB	Share
GID	Form604 Notice of change of interests of substantial holder		12/05/14	40.74KB	Share
GID	Ceasing to be a substantial holder		09/05/14	49.75KB	Share
GID	Change in substantial holding		09/05/14	53.53KB	Share
GID	Change in substantial holding		09/05/14	50.13KB	Share
GID	Change in substantial holding		09/05/14	50.23KB	Share
GID	Change in substantial holding		09/05/14	53.07KB	Share
GID	ASX 3.10.5A announcement		09/05/14	55.26KB	Share
GID	Cleansing Notice		09/05/14	548.37KB	Share
GID	Appendix 3B		09/05/14	191.52KB	Share
GID	EndoBarrier Data from Research with GSK Presented at DDW	PRICE SENSITIVE	06/05/14	85.75KB	Share
GID	GI Dynamics Completes A$34.3 Million Private Placement	PRICE SENSITIVE	02/05/14	34.14KB	Share
GID	GI Dynamics to Present at the Deutsche Bank Healthcare Conf		01/05/14	37.33KB	Share
GID	Form 10 Filed with U.S. Securities and Exchange Commission		01/05/14	337.29KB	Share
GID	Notice of Annual General Meeting/Proxy Form		30/04/14	748.35KB	Share
GID	Trading Halt	PRICE SENSITIVE	30/04/14	295.52KB	Share
GID	Appendix 4C - quarterly	PRICE SENSITIVE	29/04/14	138.21KB	Share
GID	New EndoBarrier Data to be Presented at Medical Meetings		29/04/14	30.77KB	Share
GID	Briefing Call and Webcast on Financial Results for Q1 2014		15/04/14	39.24KB	Share
GID	EndoBarrier Receives Reimbursement Coverage in Israel	PRICE SENSITIVE	07/04/14	45.79KB	Share
GID	Expands Availability of EndoBarrier Therapy in Australia	PRICE SENSITIVE	01/04/14	60.98KB	Share
GID	Annual Report to shareholders		31/03/14	2.32MB	Share
GID	Appendix 3B		27/03/14	172.67KB	Share
GID	Preliminary Reimbursement Coverage in the Netherlands	PRICE SENSITIVE	27/03/14	32.27KB	Share
GID	Appendix 3B		21/03/14	168.87KB	Share
GID	Appendix 3B		12/03/14	175.39KB	Share
AAI +PRX ADS ADO AEH CQE AFJ AGI AVR AJD ALK ALU AMX ANI AOH AQG AQP ARP PRN ASZ ATU AVG AXZ BGA BNO BOL BTR BYI CAJ CCU CLE CFU COF CPL CRH CTP CUE CVO DCG DDR DLX DML DSH DYL EAX K2P EPW EQX WJA EVR EWC FLK FLN RHK FND NOU FSA GAP GBG GBT GCS GDI ETM GHC GID GJT GNG GOW GDA GRY GUF GXY HIG HPI IAG E88 ICN ICQ IDC DXI IPP ISN JHX JPR KPL KRL KRM VBC LSA MCE MCR MCS MEO AZT LCL SYM MNW SVR MOY MPO MRP MVP MYE NCM NCR NEA NEN NEU NSE NSR NXS OFX OMH OZL PAN PBD ATH PCL PEN PGH OVT IMM QAN AX1 REA RKN RXP SAO SBB SDF SDM SEH SHJ SIV KLS SLR SMX SWL TAP TBR TFC TGP TGZ AUK UGL VAH VED VEI VET VLW VOC VTG WBA WDS XRO ZNZ ZSP	S&P DJ Indices Announces March Quarterly Rebalance		07/03/14	98KB	Share
GID	Preliminary Final Report	PRICE SENSITIVE	28/02/14	418.42KB	Share
GID	Appendix 3B		04/02/14	178.73KB	Share
GID	Expanded Reimbursement Coverage in Germany	PRICE SENSITIVE	03/02/14	32.43KB	Share
GID	Appendix 4C - quarterly	PRICE SENSITIVE	31/01/14	138.14KB	Share
GID	Briefing Call and Webcast on Financial Results for Q4 2013		21/01/14	48.23KB	Share
GID	New Meta-Analysis Further Demonstrates Safety and Efficacy	PRICE SENSITIVE	03/12/13	102.74KB	Share
GID	Appendix 3B		20/11/13	173.19KB	Share
GID	Appendix 4C - quarterly	PRICE SENSITIVE	31/10/13	217KB	Share
GID	Change in substantial holding		29/10/13	78.31KB	Share
GID	Appendix 3B		17/10/13	168.84KB	Share
GID	OPS Reimbursement Codes Received in Germany and Switzerland	PRICE SENSITIVE	01/10/13	98.04KB	Share
GID	Clinical Research Presented at European Diabetes Meeting		26/09/13	130.71KB	Share
GID	EndoBarrier Therapy Clinical Highlights and Activities		17/09/13	79.52KB	Share
GID	Update on Progress of the ENDO Trial	PRICE SENSITIVE	12/09/13	48.87KB	Share
GID	Appendix 3B		11/09/13	168.82KB	Share

GID ENDO Trial Placed on Enrollment Hold
06/03/15	PRICE SENSITIVE	142.69KB	Share
GID Trading Halt request
05/03/15		458.73KB	Share
GID Trading Halt
05/03/15	PRICE SENSITIVE	39.91KB	Share
GID Preliminary Final Report
27/02/15	PRICE SENSITIVE	263.72KB	Share
GID Appendix 3B
11/02/15		173.15KB	Share
GID Executive Separation Agreement
03/02/15		82.33KB	Share
GID Appendix 4C - quarterly
30/01/15	PRICE SENSITIVE	140.36KB	Share
GID Appendix 3B
19/01/15		186.26KB	Share
GID Corporate Restructuring and Departure of CFO
09/12/14	PRICE SENSITIVE	44.84KB	Share
GID GI Dynamics Resumes Shipments of EndoBarrier Product
01/12/14	PRICE SENSITIVE	103.57KB	Share
GID GI Dynamics to Present at the Piper Jaffray Healthcare Conf
19/11/14		37.31KB	Share
GID Appendix 3B
14/11/14		191.09KB	Share
GID Registration Statement on Form S-8 Filed with SEC
13/11/14		281.14KB	Share
GID Results of Special Meeting of Stockholders
12/11/14		79.62KB	Share
GID Form 10-Q Filed for 3rd Quarter 2014 with SEC
11/11/14	PRICE SENSITIVE	301.16KB	Share
GID Final Director's Interest Notice
05/11/14		65.54KB	Share
GID Director Appointment/Resignation
05/11/14		30.7KB	Share
GID Change of Director's Interest Notice
31/10/14		113.73KB	Share
GID Appendix 4C - quarterly
31/10/14	PRICE SENSITIVE	139.21KB	Share
GID Notice of Extraordinary General Meeting/Proxy Form
30/10/14		42.7KB	Share
GID Application for Listing on NASDAQ Capital Market
28/10/14		30.61KB	Share
GID Briefing Call and Webcast on Financial Results for Q3 2014
28/10/14		39.33KB	Share
GID Notice of Extraordinary General Meeting/Proxy Form
23/10/14		442.88KB	Share
GID +HHL Change in substantial holding from HHL
14/10/14		110.17KB	Share
GID GI Dynamics Suspends Shipments of CE Marked Product
06/10/14	PRICE SENSITIVE	88.89KB	Share
GID Trading Halt
06/10/14	PRICE SENSITIVE	485.76KB	Share
GID Initial Director's Interest Notice
19/09/14		67.91KB	Share
GID Appendix 3B
19/09/14		173.69KB	Share
GID New Clinical Data on EndoBarrier Therapy Presented at EASD
18/09/14	PRICE SENSITIVE	90.77KB	Share
GID Appendix 3B
17/09/14		172.46KB	Share
GID Change of Director's Interest Notice
15/09/14		75.22KB	Share
GID Initial Director's Interest Notice
12/09/14		67.92KB	Share
GID GI Dynamics Appoints Daniel Moore to the Board of Directors
11/09/14		32.83KB	Share
GID Clinical Data on EndoBarrier Therapy to be Presented at EASD
09/09/14		72.17KB	Share
GID New Clinical Data on EndoBarrier Therapy Presented at IFSO
29/08/14		36.14KB	Share
GID Appointment of Michael Dale as President & CEO
29/08/14	PRICE SENSITIVE	125.65KB	Share
GID Half Yearly Report and Accounts
15/08/14	PRICE SENSITIVE	366.09KB	Share
GID Appendix 3B
14/08/14		169.44KB	Share
GID +HHL Change in substantial holding from HHL
07/08/14		115.72KB	Share
GID Appendix 4C - quarterly
31/07/14	PRICE SENSITIVE	138.92KB	Share
GID Launch of EndoBarrier Therapy Clinical Study in France
30/07/14	PRICE SENSITIVE	72.31KB	Share
GID Effectiveness of U.S. SEC Form 10 Registration Statement
21/07/14		31.45KB	Share
GID Briefing Call and Webcast on Financial Results for Q2 2014
21/07/14		39.26KB	Share
GID Appendix 3B
10/07/14		182.11KB	Share
GID Departure of CCO & Update on 2nd Quarter Revenues
02/07/14	PRICE SENSITIVE	32.42KB	Share
GID +HHL Becoming a substantial holder from HHL - corrected
20/06/14		109.29KB	Share
GID +HHL Becoming a substantial holder from HHL
19/06/14		125.07KB	Share
GID New EndoBarrier data presented at ADA meeting
16/06/14	PRICE SENSITIVE	89.21KB	Share
GID New EndoBarrier data to be presented at ADA meeting
10/06/14		32.53KB	Share
GIDChange of Director's Interest Notice
04/06/14		77.08KB	Share
GIDAppendix 3B
04/06/14		196.78KB	Share
GIDResults of Meeting
22/05/14		91.01KB	Share
GIDAnnual General Meeting - Withdrawal of Resolution 3
20/05/14		75.08KB	Share
GIDReduced Reliance on Insulin by Patients with EndoBarrier
16/05/14	PRICE SENSITIVE	35.7KB	Share
GID2014 Annual Meeting of Stockholders Webcast and Call
15/05/14		34.49KB	Share
GIDBecoming a substantial holder - CORRECTION
13/05/14		54.33KB	Share
GIDBecoming a substantial holder
13/05/14		54.28KB	Share
GIDCeasing to be a substantial holder - CORRECTION
12/05/14		50.05KB	Share
GIDTwo New Centres Offer EndoBarrier in Australia
12/05/14		44.03KB	Share
GIDForm604 Notice of change of interests of substantial holder
12/05/14		40.74KB	Share
GIDCeasing to be a substantial holder
09/05/14		49.75KB	Share
GIDChange in substantial holding
09/05/14		53.53KB	Share
GIDChange in substantial holding
09/05/14		50.13KB	Share
GIDChange in substantial holding
09/05/14		50.23KB	Share
GIDChange in substantial holding
09/05/14		53.07KB	Share
GIDASX 3.10.5A announcement
09/05/14		55.26KB	Share
GIDCleansing Notice
09/05/14		548.37KB	Share
GIDAppendix 3B
09/05/14		191.52KB	Share
GIDEndoBarrier Data from Research with GSK Presented at DDW
06/05/14	PRICE SENSITIVE	85.75KB	Share
GIDGI Dynamics Completes A$34.3 Million Private Placement
02/05/14	PRICE SENSITIVE	34.14KB	Share
GIDGI Dynamics to Present at the Deutsche Bank Healthcare Conf
01/05/14		37.33KB	Share
GIDForm 10 Filed with U.S. Securities and Exchange Commission
01/05/14		337.29KB	Share
GIDNotice of Annual General Meeting/Proxy Form
30/04/14		748.35KB	Share
GIDTrading Halt
30/04/14	PRICE SENSITIVE	295.52KB	Share
GIDAppendix 4C - quarterly
29/04/14	PRICE SENSITIVE	138.21KB	Share
GIDNew EndoBarrier Data to be Presented at Medical Meetings
29/04/14		30.77KB	Share
GIDBriefing Call and Webcast on Financial Results for Q1 2014
15/04/14		39.24KB	Share
GIDEndoBarrier Receives Reimbursement Coverage in Israel
07/04/14	PRICE SENSITIVE	45.79KB	Share
GIDExpands Availability of EndoBarrier Therapy in Australia
01/04/14	PRICE SENSITIVE	60.98KB	Share
GIDAnnual Report to shareholders
31/03/14		2.32MB	Share
GIDAppendix 3B
27/03/14		172.67KB	Share
GIDPreliminary Reimbursement Coverage in the Netherlands
27/03/14	PRICE SENSITIVE	32.27KB	Share
GIDAppendix 3B
21/03/14		168.87KB	Share
GIDAppendix 3B
12/03/14		175.39KB	Share
AAI +PRX ADS ADO AEH CQE AFJ AGI AVR AJD ALK ALU AMX ANI AOH AQG AQP ARP PRN ASZ ATU AVG AXZ BGA BNO BOL BTR BYI CAJ CCU CLE CFU COF CPL CRH CTP CUE CVO DCG DDR DLX DML DSH DYL EAX K2P EPW EQX WJA EVR EWC FLK FLN RHK FND NOU FSA GAP GBG GBT GCS GDI ETM GHC GID GJT GNG GOW GDA GRY GUF GXY HIG HPI IAG E88 ICN ICQ IDC DXI IPP ISN JHX JPR KPL KRL KRM VBC LSA MCE MCR MCS MEO AZT LCL SYM MNW SVR MOY MPO MRP MVP MYE NCM NCR NEA NEN NEU NSE NSR NXS OFX OMH OZL PAN PBD ATH PCL PEN PGH OVT IMM QAN AX1 REA RKN RXP SAO SBB SDF SDM SEH SHJ SIV KLS SLR SMX SWL TAP TBR TFC TGP TGZ AUK UGL VAH VED VEI VET VLW VOC VTG WBA WDS XRO ZNZ ZSPS&P DJ Indices Announces March Quarterly Rebalance
07/03/14		98KB	Share
GIDPreliminary Final Report
28/02/14	PRICE SENSITIVE	418.42KB	Share
GIDAppendix 3B
04/02/14		178.73KB	Share
GIDExpanded Reimbursement Coverage in Germany
03/02/14	PRICE SENSITIVE	32.43KB	Share
GIDAppendix 4C - quarterly
31/01/14	PRICE SENSITIVE	138.14KB	Share
GIDBriefing Call and Webcast on Financial Results for Q4 2013
21/01/14		48.23KB	Share
GIDNew Meta-Analysis Further Demonstrates Safety and Efficacy
03/12/13	PRICE SENSITIVE	102.74KB	Share
GIDAppendix 3B
20/11/13		173.19KB	Share
GIDAppendix 4C - quarterly
31/10/13	PRICE SENSITIVE	217KB	Share
GIDChange in substantial holding
29/10/13		78.31KB	Share
GIDAppendix 3B
17/10/13		168.84KB	Share
GIDOPS Reimbursement Codes Received in Germany and Switzerland
01/10/13	PRICE SENSITIVE	98.04KB	Share
GIDClinical Research Presented at European Diabetes Meeting
26/09/13		130.71KB	Share
GIDEndoBarrier Therapy Clinical Highlights and Activities
17/09/13		79.52KB	Share
GIDUpdate on Progress of the ENDO Trial
12/09/13	PRICE SENSITIVE	48.87KB	Share
GIDAppendix 3B
11/09/13		168.82KB	Share

REFRESH

First 2 3 4 5

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

GI DYNAMICS, INC - Announcements

Corporate SpotlightNot Yet Available

Announcements

Top Stories

Corporate Spotlight
Not Yet Available